Donald Trump’s tariff move may hit global drug supplies, including top weight loss jabs like Mounjaro and Ozempic, used by ...

In a report released on April 9, Tim Anderson from Bank of America Securities maintained a Buy rating on Eli Lilly and ...

British industry leaders fear tariffs imposed by President Trump could disrupt the supply and even the price of drugs ...

Eli Lilly's foray into telehealth shows the emerging importance virtual care platforms are playing in the rising popularity ...

Weight loss platform Noom launched a full-page print ad in The Wall Street Journal this week, calling on policymakers to create new guidance around expensive drugs, as compounded GLP-1s are set to be ...

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

But this is just the start. GLP-1 drugs (specifically Novo Nordisk’s Ozempic, Rybelsus and Wegovy and Eli Lilly’s Mounjaro ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

A woman felt like she was being “ripped open by a knife” after suffering extreme reaction to single weight loss jab Mounjaro.

Some industries have escaped these moves by the administration, at least for now. One of them is the pharmaceutical industry.

Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...